MENLO PARK, Calif., Dec. 14, 2016 -- Landec Corporation (Nasdaq:LNDC) will hold a conference call on Thursday January 5, 2017 at 8 a.m. Pacific time to discuss its results for the second quarter fiscal 2017. Financial results will be reported for the 2017 fiscal second quarter ended November 27, 2016 after market close on January 4, 2017.
Landec's President and CEO, Molly Hemmeter, will host the Conference Call with Gregory S. Skinner, Vice President and CFO. A question and answer period will follow the presentation.
Date: Thursday January 5, 2017
Time: 8 a.m. Pacific time (11 a.m. Eastern time)
Toll Free Participant Dial-in Number: (844) 860-6243
U.S. and International Toll Number: (661) 378-9884
Conference ID: 36423826
Webcast: www.Landec.com/earningscall
The webcast will be available for 30 days through February 4, 2017.
A replay of the teleconference will be available for one week until midnight Eastern time, Thursday, January 12, 2017.
Toll free replay dial in: (855) 859-2056
International replay: (404) 537-3406
Replay passcode: 36423826
About Landec Corporation
Landec Corporation (NASDAQ:LNDC) is a leading innovator of diversified health and wellness solutions within the packaged food and biomaterial markets. Apio, Landec’s food business, is the leader in branded, packaged fresh vegetables in North America, utilizing its proprietary BreatheWay® packaging technology to naturally extend the shelf life of fresh produce. Apio combines this technology with the capabilities of a large national fresh produce supplier to offer healthy fresh vegetable products under the Eat Smart® brand to consumers through club and retail grocery stores. Lifecore Biomedical, Landec’s biomaterial business, is a fully integrated Contract Development and Manufacturing Organization (CDMO) that offers expertise and capabilities in fermentation, specialty formulation, aseptic filling and final packaging for FDA regulated medical devices and drugs to customers for applications in a wide array of markets including Ophthalmic, Orthopedic and Oncology. For more information about the company, visit Landec’s website at www.landec.com.
CONTACT: Media and Industry Contact: At the Company: Gregory S. Skinner Vice President Finance and CFO (650) 261-3677 Investor Relations: ICR, Inc. John Mills, Partner (646) 277-1254 [email protected]


First Western Ship Transits Strait of Hormuz Since Iran War Began
Apple Turns 50: From Garage Startup to AI Crossroads
Russell 1000 Companies Hit $2.2T Cash Record While Aggressively Reinvesting in Growth
Tesla Q1 2026 Deliveries Miss Estimates as AI Strategy Takes Center Stage
Star Entertainment Secures $390M Refinancing Deal to Stabilize Operations
Elon Musk Ties SpaceX IPO Access to Mandatory Grok AI Subscriptions
Microsoft Eyes $7B Texas Energy Deal to Power AI Data Centers
Nike Beats Q3 Estimates but China Weakness and Margin Pressure Weigh on Outlook
Fonterra Admits Anchor Butter "Grass-Fed" Label Misled Consumers After Greenpeace Lawsuit
Europe's Aviation Sector on Track to Meet 2025 Green Fuel Mandate
Private Credit Under Pressure: Is a Slow-Motion Crisis Unfolding?
TSMC Japan's Second Fab to Produce 3nm Chips by 2028
Ukrainian Drones and the #MadeByHousewives Movement: Kyiv Fires Back at Rheinmetall CEO
MATCH Act Targets ASML and Chinese Chipmakers in New U.S. Export Crackdown
Annie Altman Amends Sexual Abuse Lawsuit Against OpenAI CEO Sam Altman
OpenAI Executive Shake-Up Ahead of Anticipated 2026 IPO
Trump Administration Plans 100% Tariffs on Pharmaceutical Imports 



